Explore solutions to your questions about best practices to assess influenza via telehealth, strategies for influenza prophylaxis, and selecting antivirals for children, adolescents, and adults, including patients at high risk of influenza complications.

With the expanding use of SGLT2 inhibitors beyond glucose control, this AI-driven activity will inform clinicians about the available evidence assessing their efficacy and safety in CKD, renoprotective benefits in patients with CKD with and without T2DM, evolving practice standards, and their relevance to patient care.

In this on-demand video webinar, Dr. Paul Auwaerter discusses potential COVID-19 treatments currently in the pipeline.

 Develop patient-centered treatment strategies for NTM-LD that align with the latest evidence-based guideline recommendations and therapeutic advances

Summarize diagnostic criteria and management guidelines in the evaluation and treatment of Sickle Cell Disease

Demonstrate appropriate, guideline-based decision-making related to the selection, initiation, and duration of pharmacotherapy for patients with VTE